Oral contraceptive use and the risk of breast cancer

Research output: Contribution to journalReview articlepeer-review

33 Scopus citations


The clinical impact of the association between oral contraceptive (OC) use and breast cancer risk is important given that OCs are the most commonly prescribed contraceptive agent and that more than a quarter of a million women are diagnosed as having breast cancer in the United States annually. Substantial changes to OC formulations have been made during the past decade, and this review focuses on recent OC trends and risks and benefits. We also have a better understanding of how estrogen affects breast carcinogenesis; research on this topic is ongoing and has the goal of decreasing breast cancer incidence and mortality.

Original languageEnglish (US)
Pages (from-to)86-91
Number of pages6
JournalMayo Clinic proceedings
Issue number1
StatePublished - Jan 2008

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Oral contraceptive use and the risk of breast cancer'. Together they form a unique fingerprint.

Cite this